500
0
0
Skip to Content
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
Overview
Our Board
News
Policy
Organisation news
Events
Access
Prevention & risk
11th Report
11th Report Press Release
10th Report
English
Lung Cancer Europe | Advocacy and Access for Lung Cancer in Europe
Overview
Our Board
News
Policy
Organisation news
Events
Access
Prevention & risk
11th Report
11th Report Press Release
10th Report
English
Folder: Who We Are
Back
Overview
Our Board
Folder: News
Back
News
Policy
Organisation news
Events
Access
Prevention & risk
Folder: Annual Reports
Back
11th Report
11th Report Press Release
10th Report
English
Back
We Are Looking for People Affected by Lung Cancer to Join Our New Advisory Board
LuCE News, News, Policy Web Team 30/04/2026 LuCE News, News, Policy Web Team 30/04/2026

We Are Looking for People Affected by Lung Cancer to Join Our New Advisory Board

Read More
How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe
LuCE News, Policy, News Web Team 30/04/2026 LuCE News, Policy, News Web Team 30/04/2026

How the EU HTA Regulation is Changing Lung Cancer Treatment Assessment in Europe

Read More
Why Lung Cancer Europe Is Supporting the WECAN Open Letter on the EU Budget
Policy, LuCE News, News Web Team 27/04/2026 Policy, LuCE News, News Web Team 27/04/2026

Why Lung Cancer Europe Is Supporting the WECAN Open Letter on the EU Budget

Read More
“We Are an Organisation That Moves”: Debra Montague Opens the Inaugural Lung Cancer Europe Conference
LuCE News, News, Policy, Access Web Team 22/04/2026 LuCE News, News, Policy, Access Web Team 22/04/2026

“We Are an Organisation That Moves”: Debra Montague Opens the Inaugural Lung Cancer Europe Conference

Read More
A lung cancer mutation that has resisted treatment for decades may finally have a drug
News, Treatment, Access, Diagnosis Web Team 20/04/2026 News, Treatment, Access, Diagnosis Web Team 20/04/2026

A lung cancer mutation that has resisted treatment for decades may finally have a drug

Read More
Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece
News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026 News, LuCE News, Access, Diagnosis, Treatment Web Team 18/04/2026

Faster biomarker testing for lung cancer: our FAST-NGS pilot reaches Greece

Read More
AI That Sees Lung Scans the Way a Radiologist Does
News, Diagnosis, Advocacy Web Team 14/04/2026 News, Diagnosis, Advocacy Web Team 14/04/2026

AI That Sees Lung Scans the Way a Radiologist Does

Read More
Why does lung cancer so often spread to the brain?
News, Treatment, Prevention & risk Web Team 10/04/2026 News, Treatment, Prevention & risk Web Team 10/04/2026

Why does lung cancer so often spread to the brain?

Read More
Lung cancer screening detects other cancers too, new research finds
News, Screening, Prevention & risk Web Team 08/04/2026 News, Screening, Prevention & risk Web Team 08/04/2026

Lung cancer screening detects other cancers too, new research finds

Read More
Lung Cancer Europe welcomes a new member organisation from Kosovo
LuCE News, News, Member Organisations, Advocacy Web Team 06/04/2026 LuCE News, News, Member Organisations, Advocacy Web Team 06/04/2026

Lung Cancer Europe welcomes a new member organisation from Kosovo

Read More
Can vaping cause lung cancer? What the latest evidence says
Prevention & risk, LuCE News, News Web Team 05/04/2026 Prevention & risk, LuCE News, News Web Team 05/04/2026

Can vaping cause lung cancer? What the latest evidence says

Read More
Why biomarker testing should be routine in all NSCLC
Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026 Treatment, Diagnosis, LuCE News, News Web Team 02/04/2026

Why biomarker testing should be routine in all NSCLC

Read More
Germany launches lung cancer screening programme from 1 April
Screening, News, LuCE News, Member Organisations Web Team 01/04/2026 Screening, News, LuCE News, Member Organisations Web Team 01/04/2026

Germany launches lung cancer screening programme from 1 April

Read More
EMA recommends tarlatamab for relapsed extensive-stage SCLC
Treatment, LuCE News, News, Small Cell Lung Cancer Web Team 31/03/2026 Treatment, LuCE News, News, Small Cell Lung Cancer Web Team 31/03/2026

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Read More
Lung Cancer Europe publishes 2025 End of Year Report
News, LuCE News, Member Organisations Web Team 31/03/2026 News, LuCE News, Member Organisations Web Team 31/03/2026

Lung Cancer Europe publishes 2025 End of Year Report

Read More
Three more speakers announced for the Lung Cancer Europe Conference 2026
Event, News, LuCE News, Member Organisations, Advocacy Web Team 30/03/2026 Event, News, LuCE News, Member Organisations, Advocacy Web Team 30/03/2026

Three more speakers announced for the Lung Cancer Europe Conference 2026

Read More
10 Country Reports on Lung Cancer and Mental Health Now Available
LuCE News, News, Advocacy, Member Organisations Web Team 27/03/2026 LuCE News, News, Advocacy, Member Organisations Web Team 27/03/2026

10 Country Reports on Lung Cancer and Mental Health Now Available

Read More
Lung Cancer and Mental Health: Evidence for Change from the 11th Lung Cancer Europe Report
Advocacy, LuCE News, News, Events Web Team 27/03/2026 Advocacy, LuCE News, News, Events Web Team 27/03/2026

Lung Cancer and Mental Health: Evidence for Change from the 11th Lung Cancer Europe Report

Read More
Small Cell Lung Cancer report released alongside Lung Cancer Europe’s 11th Report on mental health
LuCE News, News, Advocacy, Member Organisations Web Team 26/03/2026 LuCE News, News, Advocacy, Member Organisations Web Team 26/03/2026

Small Cell Lung Cancer report released alongside Lung Cancer Europe’s 11th Report on mental health

Read More
Air pollution and inequality in focus at ERS Brussels event
LuCE News, News, Pollution, Prevention & risk, Advocacy Web Team 25/03/2026 LuCE News, News, Pollution, Prevention & risk, Advocacy Web Team 25/03/2026

Air pollution and inequality in focus at ERS Brussels event

Read More
Newer Posts
Older Posts

With Thanks to Our Supporters

Lung Cancer Europe is grateful to the partners who share our commitment to people affected by lung cancer. Their support helps us turn our mission into action across research, education and advocacy.

Accord Healthcare Amgen Bayer AstraZeneca BeOne Medicines BioNTech Blueprint Medicines Bristol Myers Squibb Boehringer Ingelheim Daiichi Sankyo Genmab Gilead Johnson & Johnson Lilly Merck Group MSD Novartis Novocure Pfizer PharmaCosmos PharmaMar Pierre Fabre Regeneron Roche Takeda Thermo Fisher

Connect with us on LinkedIn

Stay in the loop

You can subscribe to updates from Lung Cancer Europe by signing up to our monthly newsletter below. Our newsletter goes out on 1st of every month and we also send out news bulletins and updates.

By signing up, you agree to receive emails from Lung Cancer Europe. You can unsubscribe at any time. Read our Privacy Policy to learn how we handle your data.

PRIVACY POLICY

© Lung Cancer Europe 2026 | Designed by Laura Jones